What are the management guidelines for a cervical Pap showing low‑grade squamous intraepithelial lesion (LSIL) with a negative human papillomavirus (HPV) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of LSIL with Negative HPV Testing

For women with LSIL and a negative HPV test, repeat cytology at 12 months is the recommended approach rather than immediate colposcopy, as this combination carries a substantially lower risk of high-grade disease than LSIL with positive HPV. 1, 2

Risk Stratification

The combination of LSIL cytology with negative HPV testing represents a distinctly lower-risk scenario compared to HPV-positive LSIL:

  • The 5-year risk of CIN 2+ in HPV-negative LSIL is only 5.1% compared to 19% in HPV-positive LSIL 2
  • The 5-year risk of CIN 3+ in HPV-negative LSIL is 2.0%, which is similar to the risk for ASC-US without HPV testing (2.6%) 2
  • By the principle of "equal management of equal risks," HPV-negative LSIL should be managed similarly to ASC-US rather than requiring immediate colposcopy 2

Recommended Management Algorithm

Primary Management Strategy

  • Perform repeat cytology at 12 months (preferred approach) 1, 2
  • Alternatively, repeat cytology at both 6 and 12 months is acceptable 1
  • Immediate colposcopy is not required for this low-risk combination 2

Follow-Up Decision Points

At 12-month follow-up:

  • If repeat cytology shows ASC-US or greater: refer to colposcopy 1
  • If repeat cytology is negative: return to routine age-based screening 1

If using 6-month and 12-month cytology strategy:

  • Refer to colposcopy if any repeat test shows ASC-US or greater 1
  • Return to routine screening after two consecutive negative cytology results 1

Important Clinical Caveats

Question the Validity of HPV-Negative LSIL

The diagnosis of HPV-negative LSIL should prompt consideration of several possibilities:

  • Cytologic misinterpretation is common—only 3–11% of LSIL cases are truly HPV-negative by both Hybrid Capture 2 and PCR testing 3
  • False-negative HPV testing may occur due to sampling issues, particularly with a larger cervical os that may influence sample adequacy 3
  • At 6-month follow-up, 12–32% of initially HPV-negative LSIL cases subsequently test HPV-positive, suggesting initial sampling or testing errors 3
  • There is no evidence that HPV-negative LSIL represents a distinct biologic entity separate from HPV-related disease 3

Consider Repeat HPV Testing

  • Given the high rate of false-negative HPV results, repeat HPV testing at 12 months (rather than cytology alone) is a reasonable alternative strategy 1
  • If repeat HPV testing is positive, proceed to colposcopy 1
  • If repeat HPV testing remains negative, return to routine screening 1

Age-Specific Considerations

For women aged 21–29 years:

  • The same management applies, though this age group has higher rates of transient HPV infections 1
  • Conservative management with repeat testing is particularly appropriate 1

For women aged 30–65 years:

  • HPV positivity among LSIL cases decreases only slightly with age (88% at ages 30–34 vs. 72% at ages 60–64) 2
  • The low-risk profile of HPV-negative LSIL persists across all adult age groups 2

What NOT to Do

  • Do not perform immediate colposcopy unless there are other high-risk factors or clinical concerns 2
  • Do not perform diagnostic excisional procedures (LEEP, cone biopsy) without histologic confirmation of CIN 2/3 1
  • Do not repeat HPV testing at intervals shorter than 12 months 1

Clinical Pitfall to Avoid

The most critical pitfall is accepting the HPV-negative result at face value without considering the possibility of a false-negative test or cytologic overcall. The demographic profile of women with HPV-negative LSIL (often >35 years, fewer recent sexual partners) suggests a genuinely lower-risk population 3, but the high rate of subsequent HPV positivity on retesting indicates that many initial negative results reflect technical issues rather than true absence of HPV 3.

References

1
Guideline

Guideline Recommendations for Management of Low‑Grade Squamous Intraepithelial Lesion (LSIL)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

According to ASCCP guidelines, should a 42-year-old woman with three consecutive annual Pap tests showing low-grade squamous intraepithelial lesion (LSIL) and negative high-risk human papillomavirus (HPV) results undergo colposcopy?
What is the recommended follow‑up for a 36‑year‑old woman whose initial Pap smear showed low‑grade squamous intraepithelial lesion (LSIL) with negative high‑risk HPV, and whose subsequent Pap smears are normal (negative for intraepithelial lesion) with negative HPV?
How can I explain to a patient that her Pap test shows a low‑grade squamous intra‑epithelial lesion (LSIL) with a high‑risk human papillomavirus (HPV) infection and that a colposcopy is recommended?
In a 54-year-old woman with a Pap smear showing low-grade squamous intraepithelial lesion (LSIL) and a negative human papillomavirus (HPV) test, and no known prior cervical abnormalities, what is the appropriate management?
What is the appropriate next step in management for a 34‑year‑old woman with persistent low‑grade squamous intraepithelial lesion (LSIL) and high‑risk HPV‑positive Pap smear after a prior benign colposcopy?
What is the recommended evaluation and management for inguinal lymphadenopathy, including the appropriate contrast‑enhanced CT imaging protocol and subsequent steps based on imaging findings?
Can I continue full‑time aircraft‑maintenance duties that require kneeling, squatting, lifting, or prolonged standing while I have a knee strain?
Why is my gout worsening while taking colchicine and allopurinol, and how should I adjust the therapy?
What are the common causes of an elevated anion gap and a low anion gap?
What is the appropriate treatment for a patient who has inhaled chlorine dioxide?
What does a total antibody test for Treponema pallidum refer to?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.